Jim Simons Bellerophon Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.76 $6,764 - $13,528	-17,800 Reduced 23.03%	59,499 $24,000
Q2 2023 Aug 11, 2023	SELL	$0.68 - $12.39 $62,968 - $1.15 Million	-92,600 Reduced 54.5%	77,299 $53,000
Q1 2023 May 12, 2023	SELL	$0.9 - $7.89 $1,710 - $14,991	-1,900 Reduced 1.11%	169,899 $1.34 Million
Q4 2022 Feb 13, 2023	SELL	$0.67 - $1.2 $16,342 - $29,270	-24,392 Reduced 12.43%	171,799 $155,000
Q3 2022 Nov 14, 2022	SELL	$0.96 - $1.69 $12,679 - $22,321	-13,208 Reduced 6.31%	196,191 $214,000
Q2 2022 Aug 12, 2022	BUY	$0.85 - $2.36 $20,485 - $56,876	24,100 Added 13.01%	209,399 $258,000
Q1 2022 May 13, 2022	BUY	$1.82 - $3.24 $11,648 - $20,736	6,400 Added 3.58%	185,299 $437,000
Q4 2021 Feb 11, 2022	SELL	$2.36 - $4.05 $53,824 - $92,368	-22,807 Reduced 11.31%	178,899 $555,000
Q3 2021 Nov 12, 2021	SELL	$3.75 - $4.86 $207,622 - $269,078	-55,366 Reduced 21.54%	201,706 $819,000
Q2 2021 Aug 13, 2021	BUY	$3.83 - $5.65 $89,135 - $131,492	23,273 Added 9.95%	257,072 $1.24 Million
Q1 2021 May 13, 2021	BUY	$5.07 - $8.27 $98,865 - $161,265	19,500 Added 9.1%	233,799 $1.21 Million
Q4 2020 Feb 10, 2021	SELL	$6.12 - $10.37 $208,153 - $352,704	-34,012 Reduced 13.7%	214,299 $1.43 Million
Q3 2020 Nov 13, 2020	SELL	$9.27 - $13.79 $461,646 - $686,742	-49,800 Reduced 16.71%	248,311 $2.53 Million
Q2 2020 Aug 13, 2020	BUY	$9.43 - $20.28 $1.4 Million - $3.02 Million	148,930 Added 99.83%	298,111 $3.74 Million
Q1 2020 May 14, 2020	BUY	$3.39 - $18.0 $505,723 - $2.69 Million	149,181 New	149,181 $1.64 Million

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $573K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.